In healthcare, the cost of treating brain disorders accounts for a significant percentage of total treatment costs. In Europe, the budget for treating brain disorders alone far surpasses the combined budget for other diseases. Utilising cutting-edge AI, the EU-funded ALAMEDA project could greatly reduce the cost of treating these conditions by enabling personalised care and improved treatments for major brain disorders. The goal is to demonstrate AI-enabled prediction, prevention and intervention, making the treatment of disorders such as Parkinson’s, multiple sclerosis and strokes more affordable and easing the burden on healthcare systems across Europe.
ALAMEDA is a truly pan-European project and brings together a highly skilled and complementary consortium of 15 expert organisations from across 8 countries. The consortium is well-balanced in terms of involvement from ICT industry, academia and research as well as public and non-profit organisations.
University Politehnica of Bucharest is coordinating the WP3.
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 101017558.